These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 7506464)

  • 1. E-cadherin: a marker for differentiation and invasiveness in prostatic carcinoma.
    Otto T; Rembrink K; Goepel M; Meyer-Schwickerath M; Rübben H
    Urol Res; 1993; 21(5):359-62. PubMed ID: 7506464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-ordinated changes in expression of cell adhesion molecules in prostate cancer.
    Murant SJ; Handley J; Stower M; Reid N; Cussenot O; Maitland NJ
    Eur J Cancer; 1997 Feb; 33(2):263-71. PubMed ID: 9135498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The intercellular adhesion molecule, cadherin-10, is a marker for human prostate luminal epithelial cells that is not expressed in prostate cancer.
    Walker MM; Ellis SM; Auza MJ; Patel A; Clark P
    Mod Pathol; 2008 Feb; 21(2):85-95. PubMed ID: 18084254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of TWIST and E-cadherin expression in the metastatic progression of prostatic cancer.
    Yuen HF; Chua CW; Chan YP; Wong YC; Wang X; Chan KW
    Histopathology; 2007 Apr; 50(5):648-58. PubMed ID: 17394502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. E-cadherin is downregulated in benign prostatic hyperplasia and required for tight junction formation and permeability barrier in the prostatic epithelial cell monolayer.
    Li F; Pascal LE; Stolz DB; Wang K; Zhou Y; Chen W; Xu Y; Chen Y; Dhir R; Parwani AV; Nelson JB; DeFranco DB; Yoshimura N; Balasubramani GK; Gingrich JR; Maranchie JK; Jacobs BL; Davies BJ; Hrebinko RL; Bigley JD; McBride D; Guo P; He D; Wang Z
    Prostate; 2019 Aug; 79(11):1226-1237. PubMed ID: 31212363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E-cadherin expression as a marker of tumor aggressiveness in routinely processed radical prostatectomy specimens.
    De Marzo AM; Knudsen B; Chan-Tack K; Epstein JI
    Urology; 1999 Apr; 53(4):707-13. PubMed ID: 10197845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E-cadherin expression in prostate cancer: a broad survey using high-density tissue microarray technology.
    Rubin MA; Mucci NR; Figurski J; Fecko A; Pienta KJ; Day ML
    Hum Pathol; 2001 Jul; 32(7):690-7. PubMed ID: 11486167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of P-cadherin identifies prostate-specific-antigen-negative cells in epithelial tissues of male sexual accessory organs and in prostatic carcinomas. Implications for prostate cancer biology.
    Soler AP; Harner GD; Knudsen KA; McBrearty FX; Grujic E; Salazar H; Han AC; Keshgegian AA
    Am J Pathol; 1997 Aug; 151(2):471-8. PubMed ID: 9250159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Silencing of ezrin gene inhibits proliferation and invasion of human prostate cancer PC-3 cells].
    Yang N; Wang L; Chen X; Liu J; Luo Z
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Jun; 32(6):821-4. PubMed ID: 27371852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. E-cadherin: expression of the epithelial cell-cell-adhesion molecule in prostatic carcinoma and normal prostate.
    Rembrink K; Otto T; Goepel M; Enzawi SM; Rübben H
    Investig Urol (Berl); 1994; 5():24-7. PubMed ID: 7536522
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of some tissue and serum biomarkers in prostatic carcinoma among Egyptian males.
    Ahmed MI; Abd-Elmotelib F; Farag RM; Ziada NA; Khalifa A
    Clin Biochem; 1999 Aug; 32(6):439-45. PubMed ID: 10667479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of CEACAM1 in human prostate cancer: correlation with loss of cell polarity, increased proliferation rate, and Gleason grade 3 to 4 transition.
    Busch C; Hanssen TA; Wagener C; OBrink B
    Hum Pathol; 2002 Mar; 33(3):290-8. PubMed ID: 11979369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer.
    Umbas R; Schalken JA; Aalders TW; Carter BS; Karthaus HF; Schaafsma HE; Debruyne FM; Isaacs WB
    Cancer Res; 1992 Sep; 52(18):5104-9. PubMed ID: 1516067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations of C-MYC, NKX3.1, and E-cadherin expression in canine prostate carcinogenesis.
    Fonseca-Alves CE; Rodrigues MM; de Moura VM; Rogatto SR; Laufer-Amorim R
    Microsc Res Tech; 2013 Dec; 76(12):1250-6. PubMed ID: 24030851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cadherin switching in human prostate cancer progression.
    Tomita K; van Bokhoven A; van Leenders GJ; Ruijter ET; Jansen CF; Bussemakers MJ; Schalken JA
    Cancer Res; 2000 Jul; 60(13):3650-4. PubMed ID: 10910081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DLC1 induces expression of E-cadherin in prostate cancer cells through Rho pathway and suppresses invasion.
    Tripathi V; Popescu NC; Zimonjic DB
    Oncogene; 2014 Feb; 33(6):724-33. PubMed ID: 23376848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An inverse relation between COX-2 and E-cadherin expression correlates with aggressive histologic features in prostate cancer.
    Rao DS; Gui D; Koski ME; Popoviciu LM; Wang H; Reiter RE; Said JW
    Appl Immunohistochem Mol Morphol; 2006 Dec; 14(4):375-83. PubMed ID: 17122632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cadherin cell-cell adhesion pathway in prostate cancer progression.
    Paul R; Ewing CM; Jarrard DF; Isaacs WB
    Br J Urol; 1997 Mar; 79 Suppl 1():37-43. PubMed ID: 9088271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased expression of E-cadherin in the progression of rat prostatic cancer.
    Bussemakers MJ; van Moorselaar RJ; Giroldi LA; Ichikawa T; Isaacs JT; Takeichi M; Debruyne FM; Schalken JA
    Cancer Res; 1992 May; 52(10):2916-22. PubMed ID: 1581909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epithelial-Mesenchymal Transition Markers β-catenin, Snail, and E-Cadherin do not Predict Disease Free Survival in Prostate Adenocarcinoma: a Prospective Study.
    Ipekci T; Ozden F; Unal B; Saygin C; Uzunaslan D; Ates E
    Pathol Oncol Res; 2015 Sep; 21(4):1209-16. PubMed ID: 26037169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.